- February 12, 2016 | BY
The gut microbiome and bone health, a plea to make Zika data more accessible, and the downside in Obama’s research budget.
- February 11, 2016 | BY
Many of us make antibodies against these polymers. So why is it so hard to measure them?
- February 9, 2016 | BY
The usually benign virus is confounding scientists. What’s it going to take to solve the problem? A Q&A with tropical diseases expert Duane Gubler.
- February 5, 2016 | BY
UK regulators green-light CRISPR in human embryos, the WHO declares Zika a global emergency and why the world ignored Zika until now.
- February 3, 2016 | BY
The first in vivo genome editing compound is cleared for human trials, a major milestone in the rejuvenated field of gene therapy.
- February 1, 2016 | BY
Outsourced Pharma’s in-depth look at an issue preoccupying the microbial detection field.
- January 29, 2016 | BY
Better tests for Zika, more evidence that AD transmits, and why identical twins diverge on weight.
- January 28, 2016 | BY
An interview with cardiology expert Philip Sager on regulatory changes that are transforming cardiac safety testing.
- January 22, 2016 | BY
Stem cells and multiple sclerosis, an unusual deal to ensure the Ebola vaccine stockpile, a potential new planet on the horizon, and science at Davos.
- January 20, 2016 | BY
How are we faring in the global fight against neglected tropical diseases? A Q&A with Peter Hotez.